- Report
- August 2022
- 30 Pages
Global
From €2933EUR$3,250USD£2,548GBP
- Report
- August 2022
- 30 Pages
Global
From €2933EUR$3,250USD£2,548GBP
- Report
- August 2022
- 30 Pages
Global
From €2933EUR$3,250USD£2,548GBP
- Report
- August 2022
- 30 Pages
Global
From €2933EUR$3,250USD£2,548GBP
- Report
- February 2024
- 120 Pages
Global
From €4287EUR$4,750USD£3,724GBP
- Report
- January 2025
- 80 Pages
Saudi Arabia
From €3159EUR$3,500USD£2,744GBP
- Report
- March 2025
- 185 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- March 2025
- 182 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- February 2025
- 188 Pages
Global
From €4061EUR$4,500USD£3,528GBP
From €3159EUR$3,500USD£2,744GBP
From €3159EUR$3,500USD£2,744GBP
- Report
- September 2024
- 80 Pages
India
From €3159EUR$3,500USD£2,744GBP
- Report
- April 2024
- 183 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- February 2024
- 171 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- November 2023
- 175 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- November 2023
- 82 Pages
United States
From €3159EUR$3,500USD£2,744GBP
- Report
- October 2023
- 183 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- October 2023
- 130 Pages
Europe
From €3610EUR$4,000USD£3,136GBP
- Report
- August 2023
- 119 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- August 2023
- 117 Pages
Global
From €4061EUR$4,500USD£3,528GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more